Galapagos NV(GLPG)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GLPG Galapagos NV

未开盘 07-16 16:00:00 EDT

26.37

-0.11

-0.42%

盘后26.37

+0.000.00%

16:02 EDT

最高26.50	最低26.02	成交量5.11万
今开26.02	昨收26.48	日振幅1.81%
总市值17.38亿	流通市值11.75亿	总股本6,590万
成交额134.55万	换手率0.11%	流通股本4,454万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GLPG","market":"US","secType":"STK","nameCN":"Galapagos NV","latestPrice":26.37,"timestamp":1721160000000,"preClose":26.48,"halted":0,"volume":51073,"hourTrading":{"tag":"盘后","latestPrice":26.37,"preClose":26.37,"latestTime":"16:02 EDT","volume":315,"amount":8306.55,"timestamp":1721160170487},"delay":0,"floatShares":44543909,"shares":65897071,"eps":4.571774,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.11,"latestTime":"07-16 16:00:00 EDT","open":26.02,"high":26.5,"low":26.02,"amount":1345465.630883,"amplitude":0.018127,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.571774,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721203200000},"adr":1,"listingDate":1431576000000,"adjPreClose":26.48,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":26.01,"preClose":26.48,"latestTime":"09:29 EDT","volume":650,"amount":16907.712900000002,"timestamp":1721136570081},"postHourTrading":{"tag":"盘后","latestPrice":26.37,"preClose":26.37,"latestTime":"16:02 EDT","volume":315,"amount":8306.55,"timestamp":1721160170487},"volumeRatio":0.477815,"impliedVol":0.3333,"impliedVolPercentile":0.2937},"requestUrl":"/m/hq/s/GLPG","defaultTab":"news","newsList":[{"id":"2439667702","title":"Reg-Galapagos和Adaptimmune签署临床合作协议并可选择独家许可Adaptimmune的Tcr T细胞候选疗法Uza-Cell用于头颈癌和潜在的未来实体瘤适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2439667702","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439667702?lang=zh_cn&edition=full","pubTime":"2024-05-31 04:06","pubTimestamp":1717099579,"startTime":"0","endTime":"0","summary":"Reg-Galapagos和Adaptimmune签署临床合作协议并可选择独家许可Adaptimmune的Tcr T细胞候选疗法Uza-Cell用于头颈癌和潜在的未来实体瘤适应症","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405310406199f06ff03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405310406199f06ff03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLPG"],"gpt_icon":0},{"id":"2431317009","title":"Galapagos NV   预计每股亏损13美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431317009","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431317009?lang=zh_cn&edition=full","pubTime":"2024-04-30 19:22","pubTimestamp":1714476160,"startTime":"0","endTime":"0","summary":"   * Galapagos NV    将于5月2日公布截至2024年3月31日的季度业绩报告，预计该公司的季度收入将出现下降。* 根据 3 位分析师基于 LSEG 数据的平均估计，这家总部位于马林斯 安特卫普的公司预计营收将从去年同期的 1.7887 亿欧元降至 6587.7 万欧元，降幅为 63.2%。* LSEG 的分析师平均预计 Galapagos NV 每股亏损 13 美分。* 华尔街对 Galapagos NV 的 12 个月目标价中位数为 38.00 美元，高于其上次收盘价 28.65 美元。4月30日 - 以前的季度业绩。除非另有说明，否则所有数据均以欧元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLPG"],"gpt_icon":0},{"id":"2431980314","title":"Galapagos NV   预计每股亏损14美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431980314","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431980314?lang=zh_cn&edition=full","pubTime":"2024-04-30 19:01","pubTimestamp":1714474907,"startTime":"0","endTime":"0","summary":"   * Galapagos NV   预计将于5月2日公布截至2024年3月31日的业绩报告。*    * LSEG 的分析师平均预计 Galapagos NV 每股亏损 14 美分。* 目前分析师对该公司股票的平均评级为 \"持有\"，建议的细分为2个 \"强烈买入 \"或 \"买入\"，10个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Galapagos NV 的 12 个月目标价中位数为 40.00 欧元，高于其最新收盘价 26.76 欧元。4月30日 - 本摘要于北京时间 4 月 30 日 11:01 编辑。除非另有说明，否则所有数据均以欧元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLPG"],"gpt_icon":0},{"id":"2413976405","title":"Galapagos Nv盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413976405","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413976405?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:33","pubTimestamp":1708698839,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日22时33分，Galapagos Nv股票出现异动，股价急速下跌5.28%。截至发稿，该股报37.43美元/股，成交量1.3275万股，换手率0.02%，振幅1.19%。Galapagos Nv股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Maravai Lifesciences Hldgs Inc、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Enveric Biosciences Inc、Biodexa Pharmaceuticals Plc、Clearmind Medicine Inc较为活跃，换手率分别为255.22%、105.00%、92.81%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Maravai Lifesciences Hldgs Inc、Monopar Therapeutics Inc，振幅分别为25.00%、16.83%、12.50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322340087e72ad4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322340087e72ad4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLPG","BK4139"],"gpt_icon":0},{"id":"2413520433","title":"Galapagos NV 公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2413520433","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413520433?lang=zh_cn&edition=full","pubTime":"2024-02-23 11:02","pubTimestamp":1708657324,"startTime":"0","endTime":"0","summary":"   * Galapagos NV   公布了截至12月底的季度调整后每股收益2.39欧元，高于去年同期的每股收益3.16欧元。华尔街预期为每股亏损 4.53 欧元至 3.54 欧元。* Galapagos NV 公布的本季度每股收益为 2.39 欧元。* 公司季度净收入为 1.5756 亿欧元。2月23日 - 预测变化   * 在过去三个月中，分析师的平均盈利预测下降了约 8.3%。华尔街对 Galapagos NV 的 12 个月目标价中位数为 40.00 欧元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLPG"],"gpt_icon":0},{"id":"2412277511","title":"Galapagos NV   预计每股亏损1.18欧元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2412277511","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2412277511?lang=zh_cn&edition=full","pubTime":"2024-02-20 19:05","pubTimestamp":1708427140,"startTime":"0","endTime":"0","summary":"   * Galapagos NV    将于2月22日发布截至2023年12月31日的季度业绩报告，预计季度收入将有所增长。   * LSEG 的分析师平均预计 Galapagos NV 每股亏损 1.18 欧元。* 目前分析师对 Galapagos NV 的平均评级为 \"持有\"，建议分类为 2 个 \"强烈买入 \"或 \"买入\"，6 个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Galapagos NV 的 12 个月目标价中位数为 40.50 美元，高于其上次收盘价 39.66 美元。2月20日 - 以前的季度业绩。除非另有说明，否则所有数据均以欧元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLPG"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glpg.com","stockEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0366},{"period":"3month","weight":-0.0975},{"period":"6month","weight":-0.3031},{"period":"1year","weight":-0.3709},{"period":"ytd","weight":-0.3513}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Galapagos Nv于1999年6月30日在比利时注册成立。该公司是一家综合性生物制药公司，致力于发现、开发和商业化具有新作用模式的药物，其中一些药物目前正处于多种疾病的临床开发中，具有高度未满足的医疗需求。他们专门研究和开发基于在人类原代细胞中发现和验证的新靶点的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.049676},{"month":2,"riseRate":0.111111,"avgChangeRate":-0.082263},{"month":3,"riseRate":0.444444,"avgChangeRate":0.016596},{"month":4,"riseRate":0.555556,"avgChangeRate":-0.008218},{"month":5,"riseRate":0.333333,"avgChangeRate":0.026988},{"month":6,"riseRate":0.2,"avgChangeRate":-0.040507},{"month":7,"riseRate":0.6,"avgChangeRate":0.057251},{"month":8,"riseRate":0.111111,"avgChangeRate":-0.042586},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.032926},{"month":10,"riseRate":0.444444,"avgChangeRate":0.006373},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.008611},{"month":12,"riseRate":0.777778,"avgChangeRate":0.058321}],"exchange":"NASDAQ","name":"Galapagos NV","nameEN":"Galapagos NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Galapagos NV(GLPG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Galapagos NV(GLPG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Galapagos NV,GLPG,Galapagos NV股票,Galapagos NV股票老虎,Galapagos NV股票老虎国际,Galapagos NV行情,Galapagos NV股票行情,Galapagos NV股价,Galapagos NV股市,Galapagos NV股票价格,Galapagos NV股票交易,Galapagos NV股票购买,Galapagos NV股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Galapagos NV(GLPG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Galapagos NV(GLPG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}